Bausch + Lomb Corp's stock has dropped 7% over the past week as the company announces a leadership shakeup, raising questions about its future direction. Investors are reacting to the departure of CEO Brent Saunders, which has cast a shadow over the company's stability.
In the past week, Bausch + Lomb Corp. has faced a notable decline in its stock price, closing down 7% as the market digests the news of a CEO transition. Thomas J. Appio has been appointed as interim CEO, taking over from Brent Saunders, who left the company amid mixed performance indicators. This leadership change comes as the company anticipates raising its full-year guidance, but uncertainty remains about its execution moving forward.
Advertisement
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.15B
52W high
$25.70
52W low
$20.25
1W change
-3.53%
Beta
0.56
Analyst Price Targets
Based on analyst covering BLCO · as of Oct 16, 2026
Wall Street analysts forecast BLCO stock price to rise 7.9% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.36
+7.9% Upside
Previously C$25.50 on Oct 15, 2026
Current Price
C$23.51
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
35.4%
Annualized
90-Day Vol
31.1%
Annualized
Trend (90d)
+26.0%
Annualized drift
90d Mean
C$25.80
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$24.25 | C$21.46 – C$27.40 |
| 60 trading days | C$25.01 | C$21.04 – C$29.73 |
| 90 trading days | C$25.80 | C$20.88 – C$31.87 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent leadership changes at Bausch + Lomb may signal a period of instability, warranting caution for long-term investors.
Bausch + Lomb's Stock Decline Reflects Market Concerns Over Leadership Transition
Bausch + Lomb's stock has fallen 7% over the past week, reflecting investor apprehension following the CEO transition. This decline comes against a backdrop of a market cap of CA$8.05 billion and a forward P/E ratio of 13.77x, suggesting that while the stock is relatively affordable, the market is pricing in uncertainty about future performance.
Bull case
- The appointment of Thomas J. Appio as interim CEO could bring fresh ideas and ensure continuity in leadership, given his long history with the company.
- The company is expecting to raise its full-year guidance, which may indicate underlying strength in its operations despite the recent stock slide.
- Bausch + Lomb's focus on eye health products, especially in the dry eye disease market, could drive future growth if managed effectively.
Bear case
- The sudden departure of CEO Brent Saunders raises concerns about internal stability and strategic direction, which could impact investor confidence.
- The stock has shown weak performance metrics, including a negative profit margin and declining earnings per share, indicating potential challenges ahead.
- The market's reaction to leadership changes often reflects deeper issues within the company, which may affect long-term growth prospects.
Leadership Changes Spark Investor Concerns
Advertisement
The recent appointment of Thomas J. Appio as interim CEO has left investors questioning the future direction of Bausch + Lomb. The departure of Brent Saunders, who had been at the helm since 2023, raises concerns about the company's strategic stability. Investors often react negatively to leadership changes, especially when they come unexpectedly, as they can signal deeper issues within the organization.
Market Reaction Reflects Broader Performance Issues
Bausch + Lomb's stock performance over the past week, marked by a 7% decline, highlights ongoing challenges within the company. With a profit margin of -3.21% and an EPS of CA$-0.68, the company has struggled to maintain profitability. The leadership change may exacerbate these issues, as the market remains cautious about the company's ability to execute its growth strategy effectively.
What’s Next for Bausch + Lomb?
As Bausch + Lomb prepares to report its third-quarter results on October 28, investors will be keenly watching for any updates on guidance and performance metrics. The company's ability to maintain momentum in its product lines, particularly in the dry eye segment, will be crucial in restoring investor confidence. How the new leadership navigates these challenges will be pivotal in shaping the company's future trajectory.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
